Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial

BACKGROUND: As of mid-June 2020, 7,500,000 people were infected with SARS-CoV-2 worldwide and 420,000 people died, mainly from coronavirus disease 2019 (COVID-19)-related acute respiratory distress syndrome (ARDS). COVID-19-related ARDS is subject to a mortality rate of 50% and prolonged period of m...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazeraud, Aurélien, Gonçalves, Bruno, Aegerter, Philippe, Mancusi, Letizia, Rieu, Christine, Bozza, Fernando, Sylla, Khaoussou, Siami, Shidasp, Sharshar, Tarek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917531/
https://www.ncbi.nlm.nih.gov/pubmed/33648563
http://dx.doi.org/10.1186/s13063-021-05118-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917531/
https://www.ncbi.nlm.nih.gov/pubmed/33648563
http://dx.doi.org/10.1186/s13063-021-05118-7

Ejemplares similares